Medical Devices

A stunning quarter for Establishment Labs shows a company moving from high-growth potential to high-growth reality, underpinned by strategic discipline.

Meduloc's $4M Series B, led by GenHenn Capital and backed by Andre Ethier, fuels the launch of its innovative nitinol implant for better fracture healing.

As a major cyclospora outbreak sweeps the U.S., Roche's new research-only PCR tests provide a critical, behind-the-scenes tool for public health.

KORU Medical posts record profits, but the real story is its strategic overhaul. We dissect its oncology pivot and digital tech bet for long-term value.

GRAIL’s Galleri test shows stunning clinical results and sales growth, but staggering financial losses and a looming FDA review create a high-wire act for innovation.

Vienna's P&F acquires AVVie, gaining a novel heart valve technology. This isn't just M&A; it's a high-stakes bid to treat millions left behind.

Lifeward's pilot program with Ottobock Care isn't just a deal; it’s a strategic blueprint for scaling advanced medical tech in a new era of reimbursement.

ZAP Surgical's expansion in China is more than a business win. It signals a future where brain surgery is non-invasive, vault-free, and radically accessible.

LeMaitre reports double-digit growth driven by its Artegraft product, but misses analyst estimates. A deep dive into its global strategy and financial health.

With a strategic investment from UMass Memorial Health, Wellinks is scaling its predictive tech to prevent crises before they start. A new model for chronic care.

A $125k donation reveals a powerful new model for philanthropy, where corporate might and celebrity platforms accelerate life-changing tech for veterans.

GE HealthCare's new LOGIQ e ultrasound family isn't just a product launch; it's a strategic play to dominate point-of-care diagnostics with tiered AI-powered systems.

Saint Agatha Foundation's record grant, born from personal loss, is bringing advanced diagnostic and surgical technology to rural New York, tackling a critical gap.

GrayMatters Health hires a top insurance exec to get its novel, AI-powered PTSD therapy covered. Can digital biomarkers finally break the reimbursement barrier?

A landmark study on Haemonetics' VASCADE MVP XL system proves it enables same-day discharge for complex heart procedures, a win for patients and hospitals.

A pivotal CMS ruling grants Carlsmed's AI-driven spinal implants a dedicated payment code, unlocking market access and signaling a new era for med-tech.

A Mobile startup’s fourth patent for a surgical device isn't just an innovation; it's proof that Alabama's strategic investment in tech is building a new economy.

DeepHealth's newly FDA-cleared AI for breast ultrasound promises to standardize a complex exam, boost accuracy, and reduce radiologist workload.

As CapsoVision preps its Q2 report, investors look past the numbers to its AI-driven pipeline, a key test of its strategy to reshape GI diagnostics.

Spineway secures €1.5M in crucial financing amid rising losses, betting on its innovative ESP® disc and surgeon education to finally turn revenue into profit.